CXCL12 and melanoma: Supporting this hypothesis, CXCL12 expression was a strong independent prognostic biomarker for better survival in breast cancers [44], and administration of CXCL12 has been suggested as a potent inhibitor of colorectal and melanoma metastasis [45].